Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1650-1654

  Duncan, Christopher J A ^a,b   Barr, David A ^a   Ho, Antonia ^a   Sharp, Emma ^c   Semple, Lindsay ^a   Seaton, R Andrew ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Ceftriaxone; Glycopeptides; Native valve endocarditis; Outcomes; Prosthetic valve endocarditis; Teicoplanin

Indexed keywords

TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURVIVAL;

EID: 84877606304     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt046     Document Type: Article

References (15)

1. Andrews MM, von Reyn CF. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001; 33: 203-9.
2. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-413.
3. Partridge DG, O'Brien E, Chapman AL. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre. Postgrad Med J 2012; 88: 377-81.
4. Cervera C, del Rio A, Garcia L et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin 2011; 29: 587-92.
5. Rehm S, Campion M, Katz DE et al. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother 2009; 63: 1034-42.
6. Larioza J, Heung L, Girard A et al. Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy. South Med J 2009; 102: 575-9.
7. Amodeo MR, Clulow T, Lainchbury J et al. Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect 2009; 59: 387-93.
8. Seaton RA, Sharp E, Bezlyak V et al. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents 2011; 38: 243-8.
9. Lamont E, Seaton RA, Macpherson M et al. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme. J Antimicrob Chemother 2009; 64: 181-7.
10. Gould FK, Denning DW, Elliott TS et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012; 67: 269-89.
11. Li JS, Sexton DJ, Mick N et al. Proposedmodifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-8.
12. Mackintosh CL, White HA, Seaton RA. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother 2011; 66: 408-15.
13. Chapman AL, Seaton RA, Cooper MA et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012; 67: 1053-62.
14. Cavalcanti AB, Goncalves AR, Almeida CS et al. Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev 2010; issue 6: CD007022.
15. Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-65.